Inhibition of TGF-β signaling using recombinant human BMP-7 attenuated EndMT and reduced myocardial fibrosis in a mouse MI model, emphasizing the therapeutic potential of targeting this pathway [133]. The gene discussed is TGFB1; the disease is myocardial infarction.